Koda Health is a Houston-based digital health company that turns advance care planning into a guided, EMR-integrated digital experience. Its AI-enhanced platform helps health systems, payers, and providers scale goals-of-care conversations while letting patients create legally valid advance directives, DNR orders, and medical power-of-attorney documents at no cost. Founded in 2020 through the Texas Medical Center Biodesign program, Koda now reaches more than one million patients nationwide and pairs software with in-house clinical support to make sure care plans are understood and followed.
K2bio is a Houston-based preclinical contract research organization (CRO) built on assets acquired from Bellicum Pharmaceuticals, including a certified mouse vivarium. It pairs full-service GLP and non-GLP in vivo and in vitro research with flexible private and shared lab space near the Texas Medical Center, giving early-stage biotech and pharma teams big-company infrastructure on small-company budgets.
Sporos Bioventures is a Houston-based private biotechnology company that builds and operates a portfolio of oncology and immune-disease startups under one roof. Rather than launching companies one at a time, Sporos pools capital, drug-discovery infrastructure, and operational expertise across multiple programs - including Tvardi Therapeutics, Asylia Therapeutics, Nirogy Therapeutics, Stellanova Therapeutics, and its internal Sporos BioDiscovery group - to move targeted cancer therapies from idea to early clinical trials faster and with less duplicated risk.